Speaker Profile
M.D., Ph.D., Founder & Partner, Genesis BioCapital
Biography
A pioneer in the field of CancerImmunotherapy and next-generationtherapies; co-author of cancerimmunity cycle and the cancer immune set point. Former VP at GenentechRoche and former CMO at IGM Biosciences;Experienced drug developer that led development and global approvals for Tecentriq (anti-PDL1),entrepreneur, executive andstrategic leader;
Talk
Genesis BioCapital: Creating the Future of Medicine
Focus on Innovation, Technology, Biomarkers and Patient Selection and Company Formation
Emerging Therapeutics Showcase:
Genesis BioCapital
Envisioning a new way for company formation and venture growth in transformative medicines
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 Emerging Therapeutics Showcase will provide a 15-30 minute time slot for selected companies and researchers in the CRISPR, Cell and Gene Therapy fields. Major advancements in safer cell- and gene-level editing technologies are bringing us closer toward cures for life-threatening disorders, from cancer to HIV to Huntington’s disease. Cell therapy, in which cellular material such as T cells capable of fighting cancer cells, is injected into a patient, has been demonstrated safe and effective. The popular new CRISPR tool that has been used to edit the genetic code of nearly any organism will have an enormous impact on human health. More than a dozen clinical trials employing CRISPR on human cells are already underway.
- Emerging Therapeutics/Cell Therapy
- Emerging Therapeutics/CVD
- Emerging Therapeutics/Gene Therapy
- Emerging Therapeutics/Immunotherapy
- Emerging Therapeutics/Radiation Therapy
